Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2022-08-02 16:15:23 UTC |
---|
NP-MRD ID | NP0000619 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Glycerophosphocholine |
---|
Description | Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. GPC is formed in the breakdown of phosphatidylcholine (PtC). This pathway is active in many body tissues, including mammary tissue. |
---|
Structure | C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(2R)-2,3-Dihydroxypropyl 2-(trimethylammonio)ethyl phosphate | ChEBI | Alfoscerate de choline | ChEBI | Alfoscerato de colina | ChEBI | alpha-Glycerophosphorylcholine | ChEBI | Choline alphoscerate | ChEBI | Choline glycerophosphate | ChEBI | Cholini alfosceras | ChEBI | Cholini glycerophosphas | ChEBI | Glicerofosfato de colina | ChEBI | Glycerol phosphorylcholine | ChEBI | Glycerol-3-phosphatidylcholine | ChEBI | Glycerol-3-phosphocholine | ChEBI | Glycerophosphate de choline | ChEBI | Glycerophosphorylcholine | ChEBI | GPCho | ChEBI | L-alpha-Glycerophosphocholine | ChEBI | L-alpha-Glycerophosphorylcholine | ChEBI | L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt | ChEBI | sn-3-GPC | ChEBI | sn-Glycero-3-phosphocholine | ChEBI | sn-Glycerol 3-phosphocholine | ChEBI | Gliatilin | Kegg | (2R)-2,3-Dihydroxypropyl 2-(trimethylammonio)ethyl phosphoric acid | Generator | Alfosceric acid de choline | Generator | a-Glycerophosphorylcholine | Generator | Α-glycerophosphorylcholine | Generator | Choline alphosceric acid | Generator | Choline glycerophosphoric acid | Generator | Glycerophosphoric acid de choline | Generator | L-a-Glycerophosphocholine | Generator | L-Α-glycerophosphocholine | Generator | L-a-Glycerophosphorylcholine | Generator | L-Α-glycerophosphorylcholine | Generator | L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphoric acid inner salt | Generator | Choline alfosceric acid | HMDB | Glycerol 3 phosphocholine | HMDB | Glycerylphosphorylcholine | HMDB | Alphoscerate, choline | HMDB | L alpha Glycerylphosphorylcholine | HMDB | 3-Phosphocholine, glycerol | HMDB | Glycerol 3-phosphocholine | HMDB | L-alpha-Glycerylphosphorylcholine | HMDB | Alfoscerate, choline | HMDB | Glycerophosphate, choline | HMDB | 2-[[(2,3-Dihydroxypropoxy)hydroxyphosphinyl]oxy]-N,N,N-trimethyl-ethanaminium inner salt | HMDB | a-Glycerylphosphorylcholine | HMDB | alpha-Glycerylphosphorylcholine | HMDB | Choline alfoscerate | HMDB | Glycerophosphatidylcholine | HMDB | GPC | HMDB | Hydrogen glycerophosphate choline | HMDB | Cereton | HMDB | Cholicerin | HMDB | Cholitiline | HMDB | Delecit | HMDB | Glycerol 3-phosphorylcholine | HMDB | Glycerophosphoric acid choline ester | HMDB | Glyceryl 3-phosphorylcholine | HMDB | Glycerylphosphocholine | HMDB | L-alpha-GPC | HMDB | L-Α-GPC | HMDB | L-Α-glycerylphosphorylcholine | HMDB | O-(sn-Glycero-3-phosphoryl)-choline | HMDB | sn-Glycero-3-phosphorylcholine | HMDB | Α-glycerylphosphorylcholine | HMDB | Glycerophosphocholine | ChEBI |
|
---|
Chemical Formula | C8H20NO6P |
---|
Average Mass | 257.2230 Da |
---|
Monoisotopic Mass | 257.10282 Da |
---|
IUPAC Name | (2-{[(2R)-2,3-dihydroxypropyl phosphono]oxy}ethyl)trimethylazanium |
---|
Traditional Name | (2-{[(2R)-2,3-dihydroxypropyl phosphono]oxy}ethyl)trimethylazanium |
---|
CAS Registry Number | 28319-77-9 |
---|
SMILES | C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO |
---|
InChI Identifier | InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1 |
---|
InChI Key | SUHOQUVVVLNYQR-MRVPVSSYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, simulated) | Ahselim | | | 2022-08-02 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as glycerophosphocholines. These are lipids containing a glycerol moiety carrying a phosphocholine at the 3-position. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Glycerophospholipids |
---|
Sub Class | Glycerophosphocholines |
---|
Direct Parent | Glycerophosphocholines |
---|
Alternative Parents | |
---|
Substituents | - Glycero-3-phosphocholine
- Phosphocholine
- Dialkyl phosphate
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Tetraalkylammonium salt
- Quaternary ammonium salt
- 1,2-diol
- Secondary alcohol
- Organic nitrogen compound
- Organic salt
- Hydrocarbon derivative
- Primary alcohol
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Amine
- Alcohol
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Satlin A, Bodick N, Offen WW, Renshaw PF: Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist. Am J Psychiatry. 1997 Oct;154(10):1459-61. [PubMed:9326834 ]
- Walter A, Korth U, Hilgert M, Hartmann J, Weichel O, Hilgert M, Fassbender K, Schmitt A, Klein J: Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients. Neurobiol Aging. 2004 Nov-Dec;25(10):1299-303. [PubMed:15465626 ]
- Theberge J, Al-Semaan Y, Jensen JE, Williamson PC, Neufeld RW, Menon RS, Schaefer B, Densmore M, Drost DJ: Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla. Psychiatry Res. 2004 Nov 15;132(1):33-9. [PubMed:15546701 ]
- Miller BL, Lin KM, Djenderedjian A, Tang C, Hill E, Fu P, Nuccio C, Jenden DJ: Changes in red blood cell choline and choline-bound lipids with oral lithium. Experientia. 1990 May 15;46(5):454-6. [PubMed:2347393 ]
- Caetano SC, Fonseca M, Olvera RL, Nicoletti M, Hatch JP, Stanley JA, Hunter K, Lafer B, Pliszka SR, Soares JC: Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients. Neurosci Lett. 2005 Aug 26;384(3):321-6. [PubMed:15936878 ]
- Nitsch R, Pittas A, Blusztajn JK, Slack BE, Growdon JH, Wurtman RJ: Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann N Y Acad Sci. 1991;640:110-3. [PubMed:1663712 ]
- Chap HJ, Moatti JP, Mieusset R, Nieto M, Laneelle G, Bennet PJ, Mansat A, Pontonnier F, Douste-Blazy L: Simple, rapid enzymatic determination of glycerophosphocholine in human seminal plasma. Clin Chem. 1988 Jan;34(1):106-9. [PubMed:2827914 ]
- Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH, Wurtman RJ: Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Res. 1990 Dec 17;536(1-2):240-4. [PubMed:2150771 ]
- Mandal PK, McClure RJ, Pettegrew JW: Interactions of Abeta(1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studies. Neurochem Res. 2004 Dec;29(12):2273-9. [PubMed:15672550 ]
- Pomfret EA, daCosta KA, Schurman LL, Zeisel SH: Measurement of choline and choline metabolite concentrations using high-pressure liquid chromatography and gas chromatography-mass spectrometry. Anal Biochem. 1989 Jul;180(1):85-90. [PubMed:2817347 ]
- Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ: Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1671-5. [PubMed:1311847 ]
- Miller BL, Read S, Tang C, Jenden D: Differences in red blood cell choline and lipid-bound choline between patients with Alzheimer disease and control subjects. Neurobiol Aging. 1991 Jan-Feb;12(1):61-4. [PubMed:2002884 ]
- Jensen JE, Drost DJ, Menon RS, Williamson PC: In vivo brain (31)P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR Biomed. 2002 Aug;15(5):338-47. [PubMed:12203225 ]
- Zhang Q, Southall MD, Mezsick SM, Johnson C, Murphy RC, Konger RL, Travers JB: Epidermal peroxisome proliferator-activated receptor gamma as a target for ultraviolet B radiation. J Biol Chem. 2005 Jan 7;280(1):73-9. Epub 2004 Oct 29. [PubMed:15516334 ]
- Fallbrook A, Turenne SD, Mamalias N, Kish SJ, Ross BM: Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Res. 1999 Jul 10;834(1-2):207-10. [PubMed:10407117 ]
- Blank ML, Smith ZL, Fitzgerald V, Snyder F: The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity. Biochim Biophys Acta. 1995 Feb 9;1254(3):295-301. [PubMed:7857969 ]
- Du P, Wang G, Hu T, Li H, An Z: Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir. Front Pharmacol. 2022 Jan 5;12:779135. doi: 10.3389/fphar.2021.779135. eCollection 2021. [PubMed:35069201 ]
|
---|